CHORDIA THERAPEUTICS INC (190A.T)

JPY 240.0

(12.15%)

Market Cap (In JPY)

16.41 Billion

Revenue (In JPY)

-

Net Income (In JPY)

-1.82 Billion

Avg. Volume

2.31 Million

Currency
JPY
Country
-
Open
-
Prev. Close
-
Day Range
-
Year Range
142.0-930.0
PE
-7.71
EPS
-31.12
Beta Value
0.0
ISIN
JP3283730004
CUSIP
-
CIK
-
Shares
68388800.0
Earnings Annoncement
-

Company Profile

Sector
Industry
Pharmaceutical
CEO
-
Employee Count
-
Website
https://www.chordiatherapeutics.com/en/index.html
Ipo Date
Details
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.